Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001576990 | SCV001804292 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23952244) |
Labcorp Genetics |
RCV001576990 | SCV002470584 | benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260208 | SCV002539520 | benign | Bohring-Opitz syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568494 | SCV003732986 | likely benign | Inborn genetic diseases | 2024-10-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001576990 | SCV004152578 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ASXL1: BP4, BS1 |